Single-Port Video-Assisted Thoracoscopic Major Lung Resections: Experience with 150 Consecutive Cases
- Authors
- Ng, Calvin S. H.; Kim, Hyun Koo; Wong, Randolph H. L.; Yim, Anthony P. C.; Mok, Tony S. K.; Choi, Young Ho
- Issue Date
- 6월-2016
- Publisher
- GEORG THIEME VERLAG KG
- Keywords
- thoracoscopy; lung cancer; surgery
- Citation
- THORACIC AND CARDIOVASCULAR SURGEON, v.64, no.4, pp.348 - 353
- Indexed
- SCIE
SCOPUS
- Journal Title
- THORACIC AND CARDIOVASCULAR SURGEON
- Volume
- 64
- Number
- 4
- Start Page
- 348
- End Page
- 353
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/88462
- DOI
- 10.1055/s-0034-1396789
- ISSN
- 0171-6425
- Abstract
- Background Video-assisted thoracic surgery (VATS) for major lung resection has undergone major changes from three or four-port approach to the recently possible single-port VATS approach. Outcomes following single-port VATS major lung resection are analyzed to determine safety and efficacy. Methods A prospective database of 150 consecutive patients who underwent single-port VATS major lung resection between March 2012 and January 2014 was reviewed. Patient demographics, perioperative parameters, histopathology, and outcomes up to follow-up of 2 years were analyzed by descriptive and Kaplan-Meier survival statistics. Results Single-port VATS major lung resection was successfully performed in 142 patients (conversion rate 5.3%) for both malignant and benign diseases of the lung. Overall, 130 patients (87%) had nonsmall-cell lung carcinoma (NSCLC), 9 (6%) had other types of primary lung cancer, and the remaining for secondary malignancies and benign diseases. Among the 130 patients with NSCLC, 93 (71.5%) were stage I, 28 were stage II (21.5%), and 9 (7%) were stage III or greater. There was no intraoperative or 30-day mortality. However, one perioperative death occurred on day 49, and another on day 60 postoperatively due to infective causes. The overall 2-year mortality rate for all patients was 3%. The disease-free survival rate for subgroups, stage I NSCLC, and stage II or greater NSCLC were 96 and 83%, respectively. Conclusions Single-port VATS major lung resection for malignant and benign lung diseases is associated with low perioperative morbidity and mortality. Disease-free survival rates for NSCLC are acceptable and comparable with conventional VATS.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Biomedical Sciences > 1. Journal Articles
- College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.